In glioma cells, miR-130a negatively regulates the oncogenic functions of HMGB2 [60], and miR139-5p regulates the progression of osteosarcoma by modulating HMGB2 expression [61]. The gene discussed is HMGB2; the disease is central nervous system cancer.